🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to test the safety and potential benefit...
Status
Recruiting
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Start Date
2025-09-05
Trial ID
NCT07148791
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This study will test the safety of MSLN-targeted CAR-T cells at different d...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Start Date
2020-09-30
Trial ID
NCT04577326
Treatments Being Tested
The purpose of this study is to test the safety of giving the patient speci...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital
Start Date
2013-05
Trial ID
NCT01860937
We hypothesized that haploidentical NK cells kill tumor cells more efficien...
Status
Completed
Location
Seoul National University Hospital
Start Date
2009-02
Trial ID
NCT00846833
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of genetic...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-02-02
Trial ID
NCT06871410
This phase I/2 trial studies the side effects and best dose of activated na...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2014-08-11
Trial ID
NCT01898793
Both metastatic squamous non-small cell lung cancer (NSCLC) and extensive s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-04-30
Trial ID
NCT03166254
Treatments Being Tested
This is a multi-center prospective rater-masked (blinded) randomized contro...
Status
Recruiting
Location
Stanford Multiple Sclerosis Center
Start Date
2019-12-19
Trial ID
NCT04047628
Treatments Being Tested
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childre...
Status
Recruiting
Location
National University of Medical Sciences, Clinical Trial Unit
Start Date
2026-06-01
Trial ID
NCT07695012
Treatments Being Tested